Sigyn Therapeutics™ Announces Filing of 2023 Annual Report on SEC Form 10-K
February 21, 2024 08:45 ET
|
Sigyn Therapeutics, Inc.
SAN DIEGO, CA, Feb. 21, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. (“Sigyn Therapeutics” or the “Company”) (OTCQB: “SIGYD” – “SIGY”), a development-stage medical technology...
Sigyn Therapeutics Completes Reverse Stock Split
February 01, 2024 18:25 ET
|
Sigyn Therapeutics, Inc.
SAN DIEGO, CA, Feb. 01, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire –Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: “SIGYD”, “SIGY”), a development-stage medical technology company,...
Sigyn Therapeutics Announces Reverse Stock Split
January 30, 2024 08:45 ET
|
Sigyn Therapeutics, Inc.
SAN DIEGO, CA, Jan. 30, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a development-stage medical technology company, today...
Sigyn Therapeutics Releases Letter to Shareholders
January 04, 2024 08:00 ET
|
Sigyn Therapeutics, Inc.
SAN DIEGO, CA, Jan. 04, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a development-stage medical technology company, today...
Sigyn Therapeutics Announces Appointment of Jerry DeCiccio as Chief Financial Officer
December 12, 2023 08:30 ET
|
Sigyn Therapeutics, Inc.
SAN DIEGO, CA, Dec. 12, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a development-stage medical technology company, today...
Sigyn Therapeutics Reports Third Quarter 2023 Financial Results
November 14, 2023 17:11 ET
|
Sigyn Therapeutics, Inc.
SAN DIEGO, CA, Nov. 14, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire –Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a development-stage medical technology company, today announces...
Sigyn Therapeutics to Present at Today’s Emerging Growth Conference and Tomorrow at the National Investment Bankers Association Conference
September 06, 2023 08:00 ET
|
Sigyn Therapeutics, Inc.
SAN DIEGO, CA, Sept. 06, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB:SIGY), a medical technology company that creates blood purification...
Sigyn Therapeutics Reports Second Quarter 2023 Financial Results
August 14, 2023 16:30 ET
|
Sigyn Therapeutics, Inc.
SAN DIEGO, CA, Aug. 14, 2023 (GLOBE NEWSWIRE) -- Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a medical technology company that creates blood purification devices to overcome...
Sigyn Therapeutics Discloses “DEVICES FOR ENHANCING THE ACTIVITY OF THERAPEUTIC ANTIBODIES” Patent Submission and Related ImmunePrep™ Trademark Application
May 17, 2023 07:00 ET
|
Sigyn Therapeutics, Inc.
SAN DIEGO, CA, May 17, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a development-stage medical technology company, disclosed today...
Sigyn Therapeutics Reports First Quarter 2023 Financial Results
May 16, 2023 07:30 ET
|
Sigyn Therapeutics, Inc.
SAN DIEGO, CA, May 16, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Sigyn Therapeutics, Inc. (“Sigyn” or the “Company”) (OTCQB: SIGY), a development-stage medical technology company, today announces...